News
Country’s pioneering scientific project GenomeIndia will yield the long-term benefit of reducing disease burden, thereby creating a healthier population in the country, said a renowned scientist on ...
In a historic announcement, Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science & Technology, ...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory ...
The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 ...
Collectively, the data from in vitro and in vivo studies using FUS, TDP-43, and C9orf72 models demonstrate that hUPF1 holds significant potential for treating the majority of patients with ALS and ...
I traveled to the iconic Asilomar Conference Grounds in Monterey Bay as one of 50 “Next Generation Leaders” invited to take ...
In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human ...
(“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced an oral poster ...
Welcome to Vir Biotechnology's First Quarter 2025 Financial ... dual masking approach continues to demonstrate potential advantages in terms of safety profile and dosing flexibility.
FABA, IIL & ABF launch Finishing School Programme in Hyderabad giving a boost to lifesciences career
FABA, IIL & ABF launch Finishing School Programme in Hyderabad giving a boost to lifesciences career: Our Bureau, Bengaluru Thursday, May 8, 2025, 17:15 Hrs [IST] In a step toward ...
South by Southwest Festival goers, local leaders and Longhorns recently gathered at UT's Hook 'Em House at Antone's to hear from an esteemed panel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results